Meghan McGarry, MD, MAS

Pediatric pulmonologist

Dr. Meghan McGarry is a pulmonologist who specializes in diagnosing and caring for babies, children and young adults with acute or chronic respiratory diseases. She provides pulmonary function testing and bronchoscopy (a procedure to examine the lung airways), and has special interests in health disparities, personalized medicine and caring for patients with cystic fibrosis.

McGarry's research investigates health disparities in Latino patients with cystic fibrosis. She also studies precision medicine in cystic fibrosis (an approach that individualizes treatment by considering factors such as genetics and environment). Her research receives support from the National Institutes of Health and Cystic Fibrosis Foundation.

McGarry earned her medical degree from the University of Washington School of Medicine. She completed a residency in pediatrics at University Hospitals Rainbow Babies & Children's Hospital. At UCSF, she completed a master of advanced study degree in clinical research, a fellowship in pediatric pulmonology and a fellowship in clinical pharmacology.

McGarry is a member of the American Academy of Pediatrics and American Thoracic Society.

Clinics

Cystic Fibrosis Center
1825 Fourth St., Sixth Floor
San Francisco, CA 94158
Appointments: (415) 353-7337
Fax: (415) 476-9278

Pulmonary Clinic
1825 Fourth St., Sixth Floor
San Francisco, CA 94158
Appointments: (415) 353-7337
Fax: (415) 476-9278

Pulmonary Function Laboratory
1825 Fourth St., Sixth Floor
San Francisco, CA 94158
Phone: (415) 476-3774
Fax: (415) 353-8675

More about Meghan McGarry

Education

University of Washington School of Medicine, MD 2009
UCSF, MAS, Clinical Research 2015

Residencies

University Hospitals Rainbow Babies & Children's Hospital, Pediatrics 2012

Fellowships

UCSF, Pediatric Pulmonology 2016
UCSF, Clinical Pharmacology 2016

Selected Research and Publications

  1. McGarry ME, Neuhaus JM, Nielson DW, Burchard E, Ly NP. Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis. Pediatr Pulmonol. 2017 Dec; 52(12):1550-1557.
  2. McGarry ME, Illek B, Ly NP, Zlock L, Olshansky S, Moreno C, Finkbeiner WE, Nielson DW. In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies. Pediatr Pulmonol. 2017 Apr; 52(4):472-479.
  3. Oh SS, Du R, Zeiger AM, McGarry ME, Hu D, Thakur N, Pino-Yanes M, Galanter JM, Eng C, Nishimura KK, Huntsman S, Farber HJ, Meade K, Avila P, Serebrisky D, Bibbins-Domingo K, Lenoir MA, Ford JG, Brigino-Buenaventura E, Rodriguez-Cintron W, Thyne SM, Sen S, Rodriguez-Santana JR, Williams K, Kumar R, Burchard EG. Breastfeeding associated with higher lung function in African American youths with asthma. J Asthma. 2017 Oct; 54(8):856-865.
  4. McGarry ME, McColley SA. Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis. Ann Am Thorac Soc. 2016 Oct; 13(10):1721-1725.
  5. McGarry ME, Castellanos E, Thakur N, Oh SS, Eng C, Davis A, Meade K, LeNoir MA, Avila PC, Farber HJ, Serebrisky D, Brigino-Buenaventura E, Rodriguez-Cintron W, Kumar R, Bibbins-Domingo K, Thyne SM, Sen S, Rodriguez-Santana JR, Borrell LN, Burchard EG. Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma. Chest. 2015 Jun; 147(6):1591-1598.
  6. Thakur N, McGarry ME, Oh SS, Galanter JM, Finn PW, Burchard EG. The lung corps' approach to reducing health disparities in respiratory disease. Ann Am Thorac Soc. 2014 May; 11(4):655-60.
  7. McGarry ME, Nielson DW. Normalization of sweat chloride concentration and clinical improvement with ivacaftor in a patient with cystic fibrosis with mutation S549N. Chest. 2013 Oct; 144(4):e1-e4.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.